Characteristics of Patients with Heart Failure and Advanced Chronic Kidney Disease (Stages 4-5) Not Undergoing Renal Replacement Therapy (ERCA-IC Study)

被引:4
|
作者
More, Sandra Valdivielso [1 ,2 ,3 ]
Elcano, Miren Vicente [1 ]
Alonso, Anna Garcia [1 ]
Sanchez, Sergi Pascual [4 ]
Herrera, Isabel Galceran [4 ]
Puig, Francesc Barbosa [4 ]
Belarte-Tornero, Laia C. [1 ,2 ,3 ]
Ruiz-Bustillo, Sonia [1 ,2 ,5 ]
Murillo, Ronald O. Morales O. [1 ,2 ]
Barrios, Clara [4 ]
Vime-Jubany, Joan [1 ]
Farre, Nuria [1 ,2 ,5 ]
机构
[1] Hosp del Mar, Dept Cardiol, Heart Failure Unit, Barcelona 08003, Spain
[2] Hosp Mar Med Res Grp IMIM, Biomed Res Grp Heart Dis, Barcelona 08003, Spain
[3] Univ Autonoma Barcelona, Dept Med, Barcelona 08193, Spain
[4] Hosp Mar, Dept Nephrol, Barcelona 08003, Spain
[5] Univ Pompeu Fabra, Dept Med, Barcelona 08002, Spain
关键词
advanced chronic kidney disease; cardiorenal; heart failure; kidney dysfunction; prognosis; mortality; CARDIOVASCULAR EVENTS; HOSPITALIZATION; DIALYSIS;
D O I
10.3390/jcm12062339
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite the frequent coexistence of heart failure (HF) in patients with advanced chronic kidney disease (CKD), it has been understudied, and little is known about its prevalence and prognostic relevance. Methods: A retrospective study of 217 patients with advanced CKD (stages 4 and 5) who did not undergo renal replacement therapy (RRT). The patients were followed up for two years. The primary outcome was all-cause death or the need for RRT. Results: Forty percent of patients had a history of HF. The mean age was 78.2 +/- 8.8 years and the mean eGFR was 18.4 +/- 5.5 mL/min/1.73 m(2). The presence of previous HF identified a subgroup of high-risk patients with a high prevalence of cardiovascular comorbidities and was significantly associated with the composite endpoint of all-cause hospitalization or need for RRT (66.7% vs. 53.1%, HR 95% CI 1.62 (1.04-2.52), p = 0.034). No differences were found in the need for RRT (27.6% vs. 32.2%, p = 0.46). Nineteen patients without HF at baseline developed HF during the follow-up and all-cause death was numerically higher (36.8 vs. 19.8%, p = 0.1). Conclusions: Patients with advanced CKD have a high prevalence of HF. The presence of previous HF identified a high-risk population with a worse prognosis that required close follow-up.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Characteristics of patients with heart failure and advanced chronic kidney disease (stages 4-5) not undergoing renal replacement therapy (ERCA-IC STUDY)
    Valdivielso, S.
    Vicente Elcano, M.
    Garcia Alonso, A.
    Pascual Sanchez, S.
    Galceran Herrera, I.
    Barbosa Puig, F.
    Belarte Tornero, L. C.
    Ruiz Bustillo, S.
    Morales Murillo, R.
    Barrios Barrera, C.
    Vime Jubany, J.
    Farre Lopez, N.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 253 - 253
  • [2] Systolic blood pressure and the risk of kidney replacement therapy and mortality in patients with chronic kidney disease stage 4-5
    Chavez-Iniguez, Jonathan S.
    Zaragoza, Jose J.
    Camacho-Guerrero, Jahir R.
    Villavicencio-Ceron, Vanessa
    Valdez-Ortiz, Rafael
    Huerta-Orozco, Ana E.
    Chavez-Alonso, Gael
    Oliva-Martinez, Ana E.
    Diaz-Villavicencio, Bladimir
    Calderon-Garcia, Clementina E.
    Gonzalez-Barajas, Jose D.
    Arizaga-Napoles, Manuel
    De La Vega-Mendez, Frida M.
    Gomez-Fregoso, Juan A.
    Rodriguez-Garcia, Francisco G.
    Navarro-Blackaller, Guillermo
    Medina-Gonzalez, Ramon
    Alcantar-Vallin, Luz
    Garcia-Garcia, Guillermo
    KIDNEY & BLOOD PRESSURE RESEARCH, 2023, 48 (01): : 556 - 567
  • [3] Review article: Bone density in patients with chronic kidney disease stages 4-5
    Ott, Susan M.
    NEPHROLOGY, 2009, 14 (04) : 395 - 403
  • [4] Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease
    Wu, Rong
    Ruan, Xing-Lin
    Ruan, Dan-Dan
    Zhang, Jian-Hui
    Wang, Han-Lu
    Zeng, Quan-Zuan
    Lu, Tao
    Gan, Yu-Mian
    Luo, Jie-Wei
    Wu, Jia-Bin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10056 - 10074
  • [5] Impact of specialised renal care in patients with chronic kidney disease stage 4-5: the implicate study
    Saudan, P.
    Marangon, N.
    Bourquin, V.
    Hadaya, K.
    Stoermann-Chopard, C.
    Martin, P-Y
    SWISS MEDICAL WEEKLY, 2009, 139 (45-46) : 10S - 10S
  • [6] ACUTE PANCREATITIS IN ADVANCED CHRONIC KIDNEY DISEASE, RENAL REPLACEMENT THERAPY AND KIDNEY TRANSPLANTED PATIENTS
    Kroner, Paul T.
    Kesler, Alex M.
    Abader, Peter
    Afsh, Mohammad
    Raimondo, Massimo
    GASTROENTEROLOGY, 2019, 156 (06) : S339 - S340
  • [7] The use of opioid receptor agonists and antagonists in the treatment of patients with advanced chronic kidney disease and undergoing renal replacement therapy
    Soltysik, Anna
    Graczyk, Michal
    Woron, Jaroslaw
    PALLIATIVE MEDICINE IN PRACTICE, 2022, 16 (04): : 233 - 241
  • [8] ACHIEVED BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE STAGE 4-5
    Al-Sodany, Ehab
    Marie, Evans
    Olof, Heimburger
    Peter, Barany
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [9] Patient characteristics, disease burden, and medication use in stage 4-5 chronic kidney disease patients
    Wetmore, James B.
    Peng, Yi
    Jackson, Scott
    Matlon, Thomas J.
    Collins, Allan J.
    Gilbertson, David T.
    CLINICAL NEPHROLOGY, 2016, 85 (02) : 101 - 108
  • [10] Maximal Exercise Capacity in Chronic Kidney Disease Stage 4-5 Patients Transitioning to Renal Replacement Therapy or Continuing Conservative Care: A Longitudinal Follow-Up Study
    Hellman, Tapio
    Lankinen, Roosa
    Hakamaeki, Markus
    Koivuviita, Niina S.
    Paerkkae, Jussi
    Kallio, Petri
    Metsaerinne, Kaj
    Jaervisalo, Mikko J.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2021, : 72 - 80